Bio-pharma innovation heavily relies on animal testing, despite the significant financial implications. Preclinical spending continues to grow, while drug markets have become increasingly niche. To bridge the gap between in vivo modeling in large animals and R&D of therapeutic drugs as well as gene therapy strategies, Gentas BioTech utilizes novel technologies and platforms. These animal models from Gentas can help predict clinical success earlier in the development process.

  • Currently under final stage of construction, our state-of-the-art experimental facility, spanning 5500 square meters (m²) or approximately 60,000 square feet (ft²), is situated within the Zhangjiang Hi-Tech Park in jinshan City, Shanghai.

     

    The facility is designed to accommodate approximately 200 cages, adhering to AAALAC standards. lt features conventional (CV), specific pathogen-free (SPF), and Animal Biosafety Level 2 (ABSL-2) areas, catering to a diverse range of research needs. Additionally, it is equipped with in vitro supporting laboratories encompassing molecular/cell biology, clinical testing, pathology, analytics, and formulation, among others.

     

    Our facility strictly follows international standards in all operations, animal welfare practices, Environmental Health and Safety (EHS), Quality Control (QC), and experimental procedures. This commitment ensures the highest quality of experiments, consistency, and accuracy of experimental data, while ensuring timely delivery.

    Our Facility